Pharvaris holder plans $87,103.82 stock sale

A Pharvaris N.V. shareholder filed a Rule 144 notice to resell 2,291 vested RSU shares, plus discloses recent 10b5-1 plan sales.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is the issuer of common shares that Berndt B.A.E. Modig has notified for potential resale under Rule 144. The notice covers 2,291 common shares, held through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $87,103.82 and a proposed sale date of September 14, 2026 on NASDAQ.

The shares were acquired from the issuer upon vesting of restricted stock units during the period of September 11–12, 2026. The notice also lists prior 10b5-1 plan sales over the past three months, each involving roughly 2,291–2,292 shares of Pharvaris common stock.

Key Figures

Shares to be sold: 2,291 shares Indicated value of securities: $87,103.82 Proposed sale date: September 14, 2026 +3 more

6 metrics

Shares to be sold 2,291 shares Common stock covered by the Rule 144 notice

Indicated value of securities $87,103.82 Value associated with the 2,291 Pharvaris common shares in the notice

Proposed sale date September 14, 2026 Proposed NASDAQ sale date for the 2,291 shares

10b5-1 sale August 14, 2026 2,292 shares; $79,685.73 Common stock sold pursuant to 10b5-1 plan

10b5-1 sale July 13, 2026 2,292 shares; $80,154.45 Common stock sold pursuant to 10b5-1 plan

10b5-1 sale June 15, 2026 2,291 shares; $71,172.89 Common stock sold pursuant to 10b5-1 plan

Key Terms

Rule 144, restricted stock units, 10b5-1

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for Berndt B.A.E. Modig Emmy Noetherweg 2 Leiden"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for PHVS shareholders?

The Form 144 filing reports that 2,291 shares of Pharvaris N.V. common stock, acquired from restricted stock unit vesting, are planned for resale under Rule 144, with an indicated value of $87,103.82 and a proposed sale date of September 14, 2026.

How many PHVS shares are covered by this new Rule 144 notice?

The notice covers 2,291 Pharvaris N.V. common shares held through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $87,103.82 and a proposed sale date of September 14, 2026 on NASDAQ.

How were the PHVS shares being sold acquired by the filer?

The filing states that the securities to be sold were acquired upon the vesting of restricted stock units from Pharvaris N.V. during the period of September 11, 2026 through September 12, 2026.

What recent 10b5-1 plan sales of PHVS shares are disclosed?

The filing lists 10b5-1 sales of Pharvaris common stock: 2,292 shares on August 14, 2026 for $79,685.73, 2,292 shares on July 13, 2026 for $80,154.45, and 2,291 shares on June 15, 2026 for $71,172.89.

On which market are the PHVS shares in this Form 144 expected to be sold?

The notice identifies Pharvaris N.V. common stock to be sold on NASDAQ, with brokerage services provided by Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza.

Who is the selling security holder in this PHVS Form 144?

The selling security holder is identified as Berndt B.A.E. Modig, with the notice dated September 14, 2026, covering sales of Pharvaris N.V. common stock under Rule 144 and disclosing related 10b5-1 plan transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:59 PM Accepted by SEC EDGAR 09/14/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643072
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N V
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	310712036410
Name of Person for Whose Account the Securities are To Be Sold	Berndt B.A,E. Modig
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2291	87103.82	68072885	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2026	Restricted Stock Units	Issuer			2291	09/11/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for Berndt B.A.E. Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	08/14/2026	2292	79685.73
10b5-1 Sales for Berndt B.A.E. Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	07/13/2026	2292	80154.45
10b5-1 Sales for Berndt B.A.E. Modig Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/15/2026	2291	71172.89

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 9/11/2026 through 9/12/2026.
Date of Notice	09/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Berndt Axel Eduard Modig
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)